Prolonging Lives

Improving Care

Reducing Costs of Healthcare

 

Do you have smart ideas on how to fix HealthCare? Do you want to be a revolutionary who will disrupt the industry?

 

We are here for you:  OKM Capital, a Venture Capital firm based in Boston, Massachusetts. We believe the Future of Medicine is Preventive, Predictive, and Personalized.

 

We invest in seed and early stage companies that focus on Digital Health: DEVICES + DATA + CONNECTIVITY. Our partners have expertise in bringing disruptive ideas to life and can leverage an extensive network of contacts in HealthCare industry.


1/6
Focus

 

 

We focus on innovative talents

 

OKM Capital is a venture capital partnership focused on early-stage integrated digital healthcare solutions. We invest in entrepreneurs developing disruptive technologies that solve large unmet medical needs. 

 

Vision

 

 

Improving people’s lives

 

Aging population, increased obesity, rising healthcare costs and increasingly fast developments in the IT sector create huge market needs for new cost-saving innovations in the healthcare space.

Strategy

 

 

Team. Market. Efficiency.

 

We look at three main criteria in our investments: team chemistry coupled with a dynamic entrepreneurial mindset; market size opportunity; and efficient capital allocation.

 

News

 

OKM Capital expands its portfolio with a recent investment into Common Sensing

June 3rd, 2016

OKM Capital expands its portfolio with a recent investment into Common Sensing, co-investing alongside Qualcomm Ventures, Sanofi-Genzyme BioVentures, Waterline Ventures and other supporters of the company's Gocap patented sensor-enabled technology designed to transform diabetes care.

Mobile ODT wins the 1st place at the MedTech competition

June 30th, 2015

Add NewsMobile ODT, an Israeli/US startup took 1st place at the MedTech competition at the Wilson Sonsini Medical Device Conference in San Francisco. Its competitors included 16 other semi-finalists with technologies ranging from Smart (Connected) Catheter for Neurogenic Bladder to software that analyzes health "Big Data" and predicts potentially catastrophic illnesses.

This year’s MIT 100K attracted a bunch of promising startups in healthcare space

May 6th, 2015

OKM Capital’s Karsten Bahlman was judging at MIT 100K competition and had a chance to evaluate ideas presented. Given the depth of MIT’s research, it is no surprise that a quarter of finalists are in HealthCare space, the primary focus of OKM's activities.

Mobile ODT’s successfully closed its next financing round and CEO Ariel Beery to present at Health 2.0 Conference in Barcelona

May 5th, 2015

Mobile ODT, OKM Capital’s portfolio company, recently closed its next financing round and is ready to launch innovative medical devices in more markets, like West Africa and India. 

OKM joined BOLT accelerator in its second fund

February 3rd, 2015

We are excited about joining the latest BOLT $25M fund as investors. BOLT is a unique early stage investor, accelerator, incubator and provider of engineering services to startups operating in the connected device space. 

MobileODT won BIRD and Grand Challenges Israel awards

January 13th, 2015

OKM Capital portfolio company Mobile ODT is on track with its plans of commercial launch of multimodal imaging technology devices. Last year BIRD foundation chose Mobile ODT as one of the four healthcare sector companies to invest in for its outstanding achievements in cancer diagnostic. 

iDoc24 won THE MOBILEYS award

January 12th, 2015

OKM Capital portfolio company iDoc24 won a prestigious Mobileys award for its FirstDerm app, that provides both consumers and businesses a faster, more convenient means to receive professional opinion on skin care. 

Karsten Bahlman: we are not that far away from solving mysteries of Alzheimer and Parkinson diseases

October 08, 2014

OKM Capital’s advisor, Karsten Bahlmann, thinks that the groundbreaking work of this year’s Nobel Prize winners in Chemistry will help to address mounting challenges in science and healthcare.

Karsten’s PhD advisor, Stefan W. Hell, is a recipient of this year’s Nobel Prize. As the Nobel committee admitted, with the help of nanoscopy scientists “can track proteins involved in Parkinson’s, Alzheimer’s and Huntington’s diseases as they aggregate”. 

Health 2.0 Conference: Can we replace Physicians with Machines and Algorithms?

September 22, 2014

Digital health is gaining more and more attention from investors, entrepreneurs and healthcare providers. But can we quickly educate consumers and physicians? While many innovations focus on cost control and big data analytics, it’s not obvious to what extent and how quickly the current “fee-for-services” model will be replaced with “fee-for-outcomes” based one.

Please reload